GAMCO Investors’s SpringWorks Therapeutics SWTX Stock Holding History

GAMCO Investors’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-136,600	Closed	-$6.42M	–	1069
2025 Q2	$6.42M	Buy	+136,600	New	+$6.08M	0.06%	307

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMCO Investors's SWTX Position: Q3 2025 in Review

GAMCO Investors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 136,600 shares — an estimated $6.42M sold.

GAMCO Investors first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $6.42M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

GAMCO Investors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
GAMCO Investors sold 136,600 SpringWorks Therapeutics shares in Q3 2025, an estimated $6.42M.
GAMCO Investors first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
GAMCO Investors's SpringWorks Therapeutics position peaked at $6.42M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on GAMCO Investors's 13F filing for Q3 2025, filed 12 Nov 2025.